All In Biotech

Investigational drug · Phase 2

PRO-203

Not approved by FDA. In 1 industry-sponsored Phase 2 or 3 trial that is active or finished in the last two years, most often for Healthy Volunteers, Systemic Sclerosis (SSc), Scleroderma, Systemic.

Phase 2

Last checked: Nov 19, 2026Latest source record: Oct 9, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations

Highest phase

Phase 2

Industry-sponsored trials

Phase 2 and 3 trials

1

1 still active

All registered trials

1

Any phase or sponsor naming "PRO-203"

First trial start

2025

Oct 27, 2025

Sponsors

Lead sponsors of its Phase 2 and 3 trials.

All registered trials by phase

Every ClinicalTrials.gov drug study naming "PRO-203", any sponsor or status.

Conditions studied

As listed on its trial records.

  • Healthy Volunteers
  • Systemic Sclerosis (SSc)
  • Scleroderma, Systemic
  • Scleroderma

Largest trials

Live from ClinicalTrials.gov: studies naming "PRO-203" as an intervention, largest first.

All trials

Newest research

PubMed records naming it or its code names, newest first.

All 3 on PubMed

Also in development for Healthy Volunteers

  • PPV2323-valent Pneumococcal Polysaccharide Vaccine, lot 1Phase 36 trials

    Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd · Healthy Volunteers, Streptococcus Pneumoniae Infection, Pneumococcal Disease

  • PCV21 vaccinePhase 35 trials

    Sanofi · Pneumococcal Immunization, Healthy Volunteers

  • TDVTAK-003, Tetravalent Dengue VaccinePhase 35 trials

    Takeda · Dengue Fever, Healthy Volunteers

  • DTap-HepB-IPV-Hib vaccineHexyon, Infanrix hexaPhase 34 trials

    Sanofi · Healthy Volunteers, Meningococcal Immunization, Pneumococcal Immunization

  • MenACYW conjugate vaccineNimenrixPhase 34 trials

    Sanofi · Healthy Volunteers, Meningococcal Immunisation, Meningococcal Immunization

  • poliomyelitis vaccinePhase 33 trials

    Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd · Healthy Volunteers, Whooping Cough, Diphtheria

  • HexaximHexaxim Vaccine, DTaP-IPV-Hib-HepB vaccinePhase 32 trials

    Sanofi · Pneumococcal Immunization, Meningococcal Immunisation, Healthy Volunteers

  • IIV-HDstandalonePhase 32 trials

    Sanofi · COVID-19 Immunization, Influenza Immunization, Immunization

Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.